he past few weeks have revealed the worst and the best in human responses to the coronavirus crisis – from the supermarket hoarders clearing the shelves to the neighbourhood groups organising help for elderly and vulnerable people.

When it comes to the pharmaceutical companies, how should we judge their response? They, after all, hold the key to ending the pandemic. Yet in one vital respect their behaviour has more in common with the supermarket hoarders than the neighbourhood groups.

Our exit strategy from the global lockdown depends on the development of an effective vaccine, as is well-known. A huge effort is under way to find such a vaccine, but we cannot afford to wait the 18 months it might take.

Image Credit:  Ted S Warren/AP

News This Week

Does Space-Time Really Exist?

Is time something that flows — or just an illusion? Exploring space-time as either a fixed “block universe” or a dynamic fabric reveals deeper mysteries about existence, change, and the very nature of reality. [...]

Sugar-Coated Nanoparticles Boost Cancer Drug Efficacy

A team of researchers at the University of Mississippi has discovered that coating cancer treatment carrying nanoparticles in a sugar-like material increases their treatment efficacy. They reported their findings in Advanced Healthcare Materials. Over a tenth of breast [...]

Nanomotors: Where Are They Now?

First introduced in 2004, nanomotors have steadily advanced from a scientific curiosity to a practical technology with wide-ranging applications. This article explores the key developments, recent innovations, and major uses of nanomotors today. A [...]